Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![EisaiGlobalOnc Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1397558872404017152.png) Eisai Oncology Medical [@EisaiGlobalOnc](/creator/twitter/EisaiGlobalOnc) on x 1256 followers
Created: 2025-07-25 13:00:01 UTC

Recruiting now for a randomized open-label dose optimization study of E7386 in combination with other anticancer drug(s) in subjects with endometrial carcinoma (EC) solid tumors, including @rne_md and other investigators. #EC #oncology


XX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1948729955007037512/c:line.svg)

**Related Topics**
[drugs](/topic/drugs)
[$4523t](/topic/$4523t)

[Post Link](https://x.com/EisaiGlobalOnc/status/1948729955007037512)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

EisaiGlobalOnc Avatar Eisai Oncology Medical @EisaiGlobalOnc on x 1256 followers Created: 2025-07-25 13:00:01 UTC

Recruiting now for a randomized open-label dose optimization study of E7386 in combination with other anticancer drug(s) in subjects with endometrial carcinoma (EC) solid tumors, including @rne_md and other investigators. #EC #oncology

XX engagements

Engagements Line Chart

Related Topics drugs $4523t

Post Link

post/tweet::1948729955007037512
/post/tweet::1948729955007037512